Stock 301101 MINGYUE OPTICAL LENS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Mingyue Optical Lens Co.,Ltd.

Equities

301101

CNE1000054R1

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
25.82 CNY +0.16% Intraday chart for Mingyue Optical Lens Co.,Ltd. -1.41% -38.32%
May. 15 Mingyue Optical Lens Co.,Ltd. Approves Cash Dividend for the Year 2023 CI
Apr. 22 Mingyue Optical Lens Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The firm trades with high earnings multiples: 26.04 times its 2024 earnings per share.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is not the most generous with respect to shareholders' compensation.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-38.32% 716M -
ALCON INC. Stock Alcon Inc.
+22.39% 43.96B
B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-0.30% 18.75B
B-
AUTEK CHINA INC. Stock Autek China Inc.
-20.50% 2.22B
D+
WARBY PARKER INC. Stock Warby Parker Inc.
+25.60% 2.11B
C+
PEGAVISION CORPORATION Stock Pegavision Corporation
+19.17% 1.13B -
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-10.65% 645M -
MENICON CO., LTD. Stock Menicon Co., Ltd.
-44.53% 632M
B-
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+57.22% 606M - -
VISCO VISION INC. Stock Visco Vision Inc.
+17.51% 494M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 301101 Stock
  4. Ratings Mingyue Optical Lens Co.,Ltd.